Los Angeles Capital Management LLC Ligand Pharmaceuticals Inc Transaction History

Los Angeles Capital Management LLC

$24.2 Billion
Q4 2024

A detailed history of Los Angeles Capital Management LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 6,561 shares of LGND stock, worth $719,676. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,561

Previous 7,090 7.46%

Holding current value

$719,676

Previous $710,000 0.99%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$99.95 - $129.9 $52,873 - $68,717	-529 Reduced 7.46%	6,561 $703,000
Q3 2024 Nov 04, 2024	SELL	$82.7 - $110.11 $10,751 - $14,314	-130 Reduced 1.8%	7,090 $710,000
Q2 2024 Aug 05, 2024	BUY	$68.53 - $87.91 $494,786 - $634,710	7,220 New	7,220 $608,000
Q2 2021 Aug 05, 2021	SELL	$113.03 - $155.64 $11,303 - $15,563	-100 Reduced 4.44%	2,151 $282,000
Q1 2021 May 05, 2021	BUY	$99.52 - $215.83 $224,019 - $485,833	2,251 New	2,251 $343,000
Q3 2020 Nov 02, 2020	SELL	$89.56 - $126.72 $177,328 - $250,905	-1,980 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$68.28 - $123.65 $135,194 - $244,827	1,980 New	1,980 $221,000
Q1 2020 May 04, 2020	SELL	$63.37 - $107.88 $257,282 - $437,992	-4,060 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$96.94 - $113.59 $632,048 - $740,606	-6,520 Reduced 61.63%	4,060 $423,000
Q3 2019 Nov 07, 2019	BUY	$86.25 - $120.16 $68,137 - $94,926	790 Added 8.07%	10,580 $1.05 Million
Q2 2019 Jul 29, 2019	SELL	$107.38 - $129.34 $402,675 - $485,025	-3,750 Reduced 27.7%	9,790 $1.12 Million
Q1 2019 Apr 25, 2019	BUY	$105.93 - $142.47 $647,761 - $871,204	6,115 Added 82.36%	13,540 $1.7 Million
Q4 2018 Feb 11, 2019	BUY	$128.36 - $272.13 $335,533 - $711,347	2,614 Added 54.33%	7,425 $1.01 Million
Q3 2018 Nov 05, 2018	BUY	$211.18 - $274.49 $403,353 - $524,275	1,910 Added 65.84%	4,811 $1.32 Million
Q1 2018 Apr 27, 2018	BUY	$138.63 - $182.62 $2,772 - $3,652	20 Added 0.69%	2,901 $479,000
Q4 2017 Feb 05, 2018	BUY	$128.36 - $147.04 $152,620 - $174,830	1,189 Added 70.27%	2,881 $394,000
Q3 2017 Nov 06, 2017	BUY	$120.91 - $137.94 $204,579 - $233,394	1,692	1,692 $230,000

Others Institutions Holding LGND

# of Institutions

276

Shares Held

18.5M

Call Options Held

30.8K

Put Options Held

5.2K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.85B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Ligand Pharmaceuticals Inc Transaction History